Clinical Trial Update: Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating envafolimab in combination with fruquintinib and chemotherapy as neoadjuvant treatment for gastric cancer, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Envafolimab (envafolimab)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Gastric Cancer | Phase 2 | Status: RECRUITING